Summary of Purpose
This study is a non-randomized, Phase 2 clinical trial designed to measure the cerebral blood flow (CBF) response to inhaled nitric oxide in acute ischemic stroke patients and healthy subjects. The monitoring is a 35 minute session during which cerebral hemodynamics will be monitored with both diffuse correlation spectroscopy (DCS) and transcranial doppler ultrasonography (TCD) while blood pressure, heart rate,...Read More →
The following dates are available for this trial. Trial information last updated on 1 May 2017.
|4 Apr 2017||13 Jan 2017||1 Feb 2019||1 Feb 2019||1 May 2017||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|